It is manifested as changes in the expression levels of IL-6, IL-12, IL-23, and other inflammatory cytokines in AD (Heppner et al., 2015) and IL-17A, IL-2, and IL-8 in Lewy body dementia (Surendranathan et al., 2018). The gene discussed is IL17A; the disease is Alzheimer disease.